HAEMORRHAGIC TRANSFORMATION STROKE

This adverse event was reported 1507 times

These drugs are most commonly taken by patients reporting HAEMORRHAGIC TRANSFORMATION STROKE:

# Drug Count
0 ALTEPLASE 441
1 RIVAROXABAN 286
2 ASPIRIN 204
3 ASPIRIN 325 MG 189
4 ASPIRIN 81 MG 189
5 DABIGATRAN ETEXILATE 144
6 DABIGATRAN ETEXILATE MESYLATE 141
7 CLOPIDOGREL 120
8 CLOPIDOGREL BISULFATE 108
9 METOPROLOL TARTRATE 76
See all common drugs associated with HAEMORRHAGIC TRANSFORMATION STROKE

HAEMORRHAGIC TRANSFORMATION STROKE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TENECTEPLASE 61 0.0381
1 ALTEPLASE 441 0.0293
2 IDARUCIZUMAB 26 0.0181
3 3% SODIUM CHLORIDE 1 0.0088
4 BIVALIRUDIN 6 0.0060
5 NICARDIPINE 24 0.0054
6 ISOPROTERENOL HYDROCHLORIDE 2 0.0046
7 BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 2 0.0045
8 EDARAVONE 7 0.0044
9 ARGATROBAN 5 0.0033
See all drugs enriched for association with HAEMORRHAGIC TRANSFORMATION STROKE

HAEMORRHAGIC TRANSFORMATION STROKE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Humanized Monoclonal Antibody Fragment [EPC] 26 0.0181
1 Anti-coagulant [EPC] 11 0.0030
2 Osmotic Diuretic [EPC] 11 0.0021
3 Lymphocyte Growth Factor [EPC] 2 0.0016
4 Factor Xa Inhibitor [EPC] 340 0.0012
5 P2Y12 Platelet Inhibitor [EPC] 96 0.0008
6 Antifibrinolytic Agent [EPC] 7 0.0007
7 Amyloid Beta-directed Antibody [EPC] 2 0.0005
8 Echinocandin Antifungal [EPC] 4 0.0005
9 Antihypoglycemic Agent [EPC] 2 0.0005
See all drug classes enriched for association with HAEMORRHAGIC TRANSFORMATION STROKE